Literature DB >> 20678967

Body mass index-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity.

Olga T Hardy1, Richard A Perugini, Sarah M Nicoloro, Karen Gallagher-Dorval, Vishwajeet Puri, Juerg Straubhaar, Michael P Czech.   

Abstract

BACKGROUND: Obesity is a strong risk factor for resistance to insulin-mediated glucose disposal, a precursor of type 2 diabetes and other disorders. However, not all obese individuals are insulin resistant. We sought to identify the molecular pathways that might cause obesity-associated insulin resistance in humans by studying the morbidly obese who were insulin sensitive versus insulin resistant, thereby eliminating obesity as a variable.
METHODS: Combining gene expression profiling with computational approaches, we determined the global gene expression signatures of omental and subcutaneous adipose tissue samples obtained from similarly obese patients undergoing gastric bypass surgery.
RESULTS: Gene sets related to chemokine activity and chemokine receptor binding were identified as most highly expressed in the omental tissue from insulin-resistant compared with insulin-sensitive subjects, independent of the body mass index. These upregulated genes included chemokines (C-C motif) ligand 2, 3, 4, and 18 and interleukin-8/(CC-X motif) ligand 8 and were not differentially expressed in the subcutaneous adipose tissues between the 2 groups of subjects. Insulin resistance, but not the body mass index, was associated with increased macrophage infiltration in the omental adipose tissue, as was adipocyte size, in these morbidly obese subjects.
CONCLUSION: Our findings have demonstrated that inflammation of the omental adipose tissue is strongly associated with insulin resistance in human obesity even in subjects with similar body mass index values. Copyright Â
© 2011 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20678967      PMCID: PMC2980798          DOI: 10.1016/j.soard.2010.05.013

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  31 in total

Review 1.  Adipocytes as regulators of energy balance and glucose homeostasis.

Authors:  Evan D Rosen; Bruce M Spiegelman
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

2.  Relationship between adipocyte size and adipokine expression and secretion.

Authors:  Thomas Skurk; Catherine Alberti-Huber; Christian Herder; Hans Hauner
Journal:  J Clin Endocrinol Metab       Date:  2006-12-12       Impact factor: 5.958

3.  Metabolic characterization of nondiabetic severely obese patients undergoing Roux-en-Y gastric bypass: preoperative classification predicts the effects of gastric bypass on insulin-glucose homeostasis.

Authors:  Richard A Perugini; Steven H Quarfordt; Stephen Baker; Donald R Czerniach; Demetrius E M Litwin; John J Kelly
Journal:  J Gastrointest Surg       Date:  2007-09       Impact factor: 3.452

4.  Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone.

Authors:  Gina B Di Gregorio; Aiwei Yao-Borengasser; Neda Rasouli; Vijayalakshmi Varma; Tong Lu; Leslie M Miles; Gouri Ranganathan; Charlotte A Peterson; Robert E McGehee; Philip A Kern
Journal:  Diabetes       Date:  2005-08       Impact factor: 9.461

5.  Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity.

Authors:  Ilana Harman-Boehm; Matthias Blüher; Henry Redel; Netta Sion-Vardy; Shira Ovadia; Eliezer Avinoach; Iris Shai; Nora Klöting; Michael Stumvoll; Nava Bashan; Assaf Rudich
Journal:  J Clin Endocrinol Metab       Date:  2007-03-20       Impact factor: 5.958

6.  A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects.

Authors:  Ingrid Dahlman; Maria Kaaman; Tommy Olsson; Garry D Tan; Alex S T Bickerton; Kerstin Wåhlén; Jonas Andersson; Elisabet Arvidsson Nordström; Lennart Blomqvist; Annelie Sjögren; Margaretha Forsgren; Anneli Attersand; Peter Arner
Journal:  J Clin Endocrinol Metab       Date:  2005-08-09       Impact factor: 5.958

Review 7.  All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals.

Authors:  Gerald Reaven
Journal:  Diab Vasc Dis Res       Date:  2005-10       Impact factor: 3.291

Review 8.  Obesity, inflammation, and insulin resistance.

Authors:  Steven E Shoelson; Laura Herrero; Afia Naaz
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

Review 9.  The macrophage at the crossroads of insulin resistance and atherosclerosis.

Authors:  Chien-Ping Liang; Seongah Han; Takafumi Senokuchi; Alan R Tall
Journal:  Circ Res       Date:  2007-06-08       Impact factor: 17.367

10.  An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPARgamma, adipogenesis, and insulin-responsive hexose transport.

Authors:  Xiaoqing Tang; Adilson Guilherme; Abhijit Chakladar; Aimee M Powelka; Silvana Konda; Joseph V Virbasius; Sarah M C Nicoloro; Juerg Straubhaar; Michael P Czech
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

View more
  94 in total

Review 1.  Macrophage polarization in pathology.

Authors:  Antonio Sica; Marco Erreni; Paola Allavena; Chiara Porta
Journal:  Cell Mol Life Sci       Date:  2015-07-26       Impact factor: 9.261

Review 2.  Nutritional approaches for managing obesity-associated metabolic diseases.

Authors:  Rachel Botchlett; Shih-Lung Woo; Mengyang Liu; Ya Pei; Xin Guo; Honggui Li; Chaodong Wu
Journal:  J Endocrinol       Date:  2017-04-11       Impact factor: 4.286

Review 3.  The initiation of metabolic inflammation in childhood obesity.

Authors:  Kanakadurga Singer; Carey N Lumeng
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

Review 4.  Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk.

Authors:  Jennifer H Stern; Joseph M Rutkowski; Philipp E Scherer
Journal:  Cell Metab       Date:  2016-05-10       Impact factor: 27.287

5.  CIDEC/FSP27 and PLIN1 gene expression run in parallel to mitochondrial genes in human adipose tissue, both increasing after weight loss.

Authors:  J M Moreno-Navarrete; F Ortega; M Serrano; J I Rodriguez-Hermosa; W Ricart; G Mingrone; J M Fernández-Real
Journal:  Int J Obes (Lond)       Date:  2013-09-12       Impact factor: 5.095

Review 6.  Adapting to obesity with adipose tissue inflammation.

Authors:  Shannon M Reilly; Alan R Saltiel
Journal:  Nat Rev Endocrinol       Date:  2017-08-11       Impact factor: 43.330

Review 7.  The expanding problem of adipose depot remodeling and postnatal adipocyte progenitor recruitment.

Authors:  Chelsea Hepler; Rana K Gupta
Journal:  Mol Cell Endocrinol       Date:  2016-10-12       Impact factor: 4.102

8.  Identification of functionally distinct fibro-inflammatory and adipogenic stromal subpopulations in visceral adipose tissue of adult mice.

Authors:  Chelsea Hepler; Bo Shan; Qianbin Zhang; Gervaise H Henry; Mengle Shao; Lavanya Vishvanath; Alexandra L Ghaben; Angela B Mobley; Douglas Strand; Gary C Hon; Rana K Gupta
Journal:  Elife       Date:  2018-09-28       Impact factor: 8.140

9.  Obesity Determines the Immunophenotypic Profile and Functional Characteristics of Human Mesenchymal Stem Cells From Adipose Tissue.

Authors:  Gisela Pachón-Peña; Carolina Serena; Miriam Ejarque; Jordi Petriz; Xevi Duran; W Oliva-Olivera; Rafael Simó; Francisco J Tinahones; Sonia Fernández-Veledo; Joan Vendrell
Journal:  Stem Cells Transl Med       Date:  2016-03-08       Impact factor: 6.940

Review 10.  Metabolically healthy obesity--does it exist?

Authors:  Patchaya Boonchaya-anant; Caroline M Apovian
Journal:  Curr Atheroscler Rep       Date:  2014-10       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.